Dersimelagon in Erythropoietic Protoporphyrias
Dersimelagon in Erythropoietic Protoporphyrias
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
The International Porphyria Patient Network welcomes additional treatments for the erythropoietic protoporphyrias, such as dersimelagon, which was described by Balwani et al. (April 13 issue).
1
New drugs could help to address the needs of underserved subgroups such as children and may provide patients and health care profes...
Alternative Titles
Full title
Dersimelagon in Erythropoietic Protoporphyrias
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2831296893
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2831296893
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc2305601
